---
$id: https://graph.org.ai/products/commodity/51121915
$type: Product
source: UNSPSC
code: "51121915"
title: "Bufogenin or resibufogenin"
class: "51121900"
classTitle: "Drugs used for congestive heart failure"
family: "51120000"
familyTitle: "Antiarrythmics and antianginals and cardioplegics and drugs for heart failure"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bufogenin or resibufogenin

**UNSPSC Code**: 51121915
**Class**: [Drugs used for congestive heart failure](Drugs used for congestive heart failure.mdx)
**Family**: [Antiarrythmics and antianginals and cardioplegics and drugs for heart failure](../Antiarrythmics and antianginals and cardioplegics and drugs for heart failure.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme inhibitor with the molecular formula C24H32O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3K654P2M4J, chemically known as 14,15beta-epoxy-3beta-hydroxy-5beta-bufa-20,22-dienolide but generally known as bufogenin, which bears US NIH Compound Identifier 10063. European Medicines Agency schedules Bufogenin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05964MIG. The term BUFOGENIN is an International Non-Proprietary Name. BUFOGENIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Bufogenin or resibufogenin bears US NLM identifiers UMLS ID C0054208 and NCI Concept Code C77829. SMILES: CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C6=COC(=O)C=C6)C)O.

